Stocks/OCUL/Filings & Earnings

OCUL SEC Filings, Earnings & Splits

Key events from SEC filings, earnings beat/miss history, stock split records, and share float data for OCUL.

What are OCUL's recent SEC filings?

8-K · Board ChangeNov 9, 2026

Ocular Therapeutix elected Riad Sherif, M.D. to its Board of Directors effective November 6, 2026, and announced that Seung Suh Hong, Ph.D. resigned from the Board effective December 31, 2026. Dr. Hong's resignation was not due to any disagreement with the Board or management.

View full filing details →
Stock option grant to Riad Sherif (88,000 shares at $6.60 exercise price): $580800, Restricted stock unit award to Riad Sherif (28,000 shares): $0
8-K · OtherNov 9, 2026

Ocular Therapeutix, Inc. furnished a Form 8-K announcing its financial results for the quarter ended September 30, 2026, with the full press release attached as Exhibit 99.1.

View full filing details →
10-Q · OtherNov 9, 2026

Ocular Therapeutix filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting routine financial results and disclosures.

View full filing details →
8-K · OtherOct 16, 2026

Ocular Therapeutix filed a routine Form 8-K cover page with no substantive event disclosed in the provided text.

View full filing details →

Has OCUL ever done a stock split?

No stock splits are recorded for OCUL.

What is OCUL's share float?

Public Float
$258.4M
Shares Outstanding
$219.6M
Free Float %
9999.0%

Get Real-Time OCUL Intelligence

SEPT X-Ray combines SEC filings with price targets, support/resistance levels, and smart money tracking — updated every 30 minutes.

Try SEPT X-Ray Free

More OCUL Research

OCUL FundamentalsOCUL AnalysisSEPT Academy
Share:XRedditFacebookLinkedIn
© SEPT Investing. Filing summaries are extracted automatically from SEC filings and may contain errors. Always verify with official SEC EDGAR filings. Trading involves risk.